Professional Overview
Özgür Uyan is a seasoned Sales Representative with a strong background in the pharmaceutical industry, currently working at Abdi Ibrahim Pharmaceuticals in Turkey. His key expertise areas include sales, product specialist, and medical representation, with a focus on the pharmaceutical sector.
Experience Summary
Current Role
Özgür Uyan is currently a Sales Representative at Abdi Ibrahim Pharmaceuticals, a position he has held since September 2024. Key responsibilities include driving sales growth, managing customer relationships, and promoting pharmaceutical products.
Career Progression
Notable previous roles include Product Sales Specialist at İlko Pharmaceuticals, Ürün Uzmanı at Hasbiotech İlaç, and Tıbbi Mümessil at Nobel İlaç. His career trajectory demonstrates consistent growth and a strong commitment to the pharmaceutical industry, with key achievements in sales and customer relationship management.
Academic Background
Özgür Uyan holds an MBA in İşletme from Ahmet Yesevi Üniversitesi, completed between 2021-2022. He also holds a Lisans Derecesi in Physical Education Teaching and Coaching from Kocaeli Üniversitesi, completed between 2001-2005.
Areas of Expertise
Industry-specific skills include pharmaceutical sales, product specialist knowledge, and medical representation. Technical competencies include sales management, customer relationship management, and product promotion.
Professional Impact
While specific project details are not available, Özgür Uyan's contributions to the pharmaceutical industry are evident through his consistent career progression and commitment to sales and customer relationship management.
Conclusion
Özgür Uyan's professional trajectory demonstrates a strong focus on the pharmaceutical industry, with consistent growth and achievements in sales and customer relationship management. Currently, he is focused on driving sales growth and promoting pharmaceutical products at Abdi Ibrahim Pharmaceuticals. His value proposition lies in his industry-specific skills, technical competencies, and leadership capabilities, making him a valuable asset to the pharmaceutical sector.